| . | All patients (N = 107) . | Patients without EMI (n = 90) . | Patients with EMI (n = 17) . | P-value . |
|---|---|---|---|---|
| Patient characteristics | ||||
| Gender, n (%) | 0.231 | |||
| Male | 93 (86.9) | 80 (88.9) | 13 (76.5) | |
| Female | 14 (13.1) | 10 (11.1) | 4 (23.5) | |
| Age (years) | 73.5 (64.6–78.3) | 73.1 (64.5–78.2) | 76.8 (69.5–79.2) | 0.257 |
| BMI (kg/m²) | 27.1 (24.8–30.9) | 27.1 (24.8–30) | 27.5 (25.1–30.5) | 0.997 |
| Cardiomyopathy, n (%) | 0.529 | |||
| Ischaemic | 55 (51.4) | 48 (53.3) | 7 (41.2) | |
| Dilated | 30 (28.0) | 24 (26.7) | 6 (35.3) | |
| Inflammatory | 7 (6.5) | 6 (6.7) | 1 (5.9) | |
| Hypertrophic | 5 (4.7) | 5 (5.6) | 0 (0) | |
| Other | 10 (9.4) | 7 (7.8) | 3 (17.7) | |
| ICD indication, n (%) | 0.773 | |||
| Primary prevention | 75 (70.1) | 64 (71.1) | 11 (64.7) | |
| Secondary prevention | 32 (29.9) | 26 (28.9) | 6 (35.3) | |
| Heart rhythm, n (%) | 0.129 | |||
| Sinus rhythm | 87 (81.3) | 76 (84.4) | 11 (64.7) | |
| Atrial fibrillation | 14 (13.1) | 10 (11.1) | 4 (23.5) | |
| Third-degree AV block | 6 (5.6) | 4 (4.4) | 2 (11.8) | |
| Device characteristics | ||||
| Device location, n (%) | 0.118 | |||
| Left pectoral | 103 (96.3) | 88 (97.8) | 15 (88.2) | |
| Right pectoral | 4 (3.7) | 2 (2.2) | 0 | |
| Sensing configuration RV, n (%) | 0.539 | |||
| True bipolar | 82 (76.6) | 70 (77.8) | 12 (70.6) | |
| Integrated bipolar | 25 (23.4) | 20 (22.2) | 5 (29.4) | |
| ICD system, n (%) | 0.083 | |||
| Single-chamber ICD | 36 (33.6) | 34 (37.8) | 2 (11.8) | |
| Dual-chamber ICD | 23 (21.5) | 19 (21.1) | 4 (23.5) | |
| CRT-D | 48 (44.9) | 37 (41.1) | 11 (64.7) | |
| Device manufacturer, n (%) | 0.012 | |||
| Medtronic | 27 (25.2) | 27 (30) | 0 (0) | |
| Biotronik | 34 (31.8) | 29 (32.2) | 5 (29.4) | |
| Boston Scientific | 25 (23.4) | 19 (21.1) | 6 (35.3) | |
| Abbott | 21 (19.6) | 15 (16.7) | 6 (35.3) | |
| . | All patients (N = 107) . | Patients without EMI (n = 90) . | Patients with EMI (n = 17) . | P-value . |
|---|---|---|---|---|
| Patient characteristics | ||||
| Gender, n (%) | 0.231 | |||
| Male | 93 (86.9) | 80 (88.9) | 13 (76.5) | |
| Female | 14 (13.1) | 10 (11.1) | 4 (23.5) | |
| Age (years) | 73.5 (64.6–78.3) | 73.1 (64.5–78.2) | 76.8 (69.5–79.2) | 0.257 |
| BMI (kg/m²) | 27.1 (24.8–30.9) | 27.1 (24.8–30) | 27.5 (25.1–30.5) | 0.997 |
| Cardiomyopathy, n (%) | 0.529 | |||
| Ischaemic | 55 (51.4) | 48 (53.3) | 7 (41.2) | |
| Dilated | 30 (28.0) | 24 (26.7) | 6 (35.3) | |
| Inflammatory | 7 (6.5) | 6 (6.7) | 1 (5.9) | |
| Hypertrophic | 5 (4.7) | 5 (5.6) | 0 (0) | |
| Other | 10 (9.4) | 7 (7.8) | 3 (17.7) | |
| ICD indication, n (%) | 0.773 | |||
| Primary prevention | 75 (70.1) | 64 (71.1) | 11 (64.7) | |
| Secondary prevention | 32 (29.9) | 26 (28.9) | 6 (35.3) | |
| Heart rhythm, n (%) | 0.129 | |||
| Sinus rhythm | 87 (81.3) | 76 (84.4) | 11 (64.7) | |
| Atrial fibrillation | 14 (13.1) | 10 (11.1) | 4 (23.5) | |
| Third-degree AV block | 6 (5.6) | 4 (4.4) | 2 (11.8) | |
| Device characteristics | ||||
| Device location, n (%) | 0.118 | |||
| Left pectoral | 103 (96.3) | 88 (97.8) | 15 (88.2) | |
| Right pectoral | 4 (3.7) | 2 (2.2) | 0 | |
| Sensing configuration RV, n (%) | 0.539 | |||
| True bipolar | 82 (76.6) | 70 (77.8) | 12 (70.6) | |
| Integrated bipolar | 25 (23.4) | 20 (22.2) | 5 (29.4) | |
| ICD system, n (%) | 0.083 | |||
| Single-chamber ICD | 36 (33.6) | 34 (37.8) | 2 (11.8) | |
| Dual-chamber ICD | 23 (21.5) | 19 (21.1) | 4 (23.5) | |
| CRT-D | 48 (44.9) | 37 (41.1) | 11 (64.7) | |
| Device manufacturer, n (%) | 0.012 | |||
| Medtronic | 27 (25.2) | 27 (30) | 0 (0) | |
| Biotronik | 34 (31.8) | 29 (32.2) | 5 (29.4) | |
| Boston Scientific | 25 (23.4) | 19 (21.1) | 6 (35.3) | |
| Abbott | 21 (19.6) | 15 (16.7) | 6 (35.3) | |
Quantitative variables are shown as median (IQR).
AV, atrioventricular; BMI, body mass index; CRT-D, cardiac resynchronization therapy with defibrillator; EMI, electromagnetic interference; ICD, implantable cardioverter-defibrillator; RV, right ventricle.
| . | All patients (N = 107) . | Patients without EMI (n = 90) . | Patients with EMI (n = 17) . | P-value . |
|---|---|---|---|---|
| Patient characteristics | ||||
| Gender, n (%) | 0.231 | |||
| Male | 93 (86.9) | 80 (88.9) | 13 (76.5) | |
| Female | 14 (13.1) | 10 (11.1) | 4 (23.5) | |
| Age (years) | 73.5 (64.6–78.3) | 73.1 (64.5–78.2) | 76.8 (69.5–79.2) | 0.257 |
| BMI (kg/m²) | 27.1 (24.8–30.9) | 27.1 (24.8–30) | 27.5 (25.1–30.5) | 0.997 |
| Cardiomyopathy, n (%) | 0.529 | |||
| Ischaemic | 55 (51.4) | 48 (53.3) | 7 (41.2) | |
| Dilated | 30 (28.0) | 24 (26.7) | 6 (35.3) | |
| Inflammatory | 7 (6.5) | 6 (6.7) | 1 (5.9) | |
| Hypertrophic | 5 (4.7) | 5 (5.6) | 0 (0) | |
| Other | 10 (9.4) | 7 (7.8) | 3 (17.7) | |
| ICD indication, n (%) | 0.773 | |||
| Primary prevention | 75 (70.1) | 64 (71.1) | 11 (64.7) | |
| Secondary prevention | 32 (29.9) | 26 (28.9) | 6 (35.3) | |
| Heart rhythm, n (%) | 0.129 | |||
| Sinus rhythm | 87 (81.3) | 76 (84.4) | 11 (64.7) | |
| Atrial fibrillation | 14 (13.1) | 10 (11.1) | 4 (23.5) | |
| Third-degree AV block | 6 (5.6) | 4 (4.4) | 2 (11.8) | |
| Device characteristics | ||||
| Device location, n (%) | 0.118 | |||
| Left pectoral | 103 (96.3) | 88 (97.8) | 15 (88.2) | |
| Right pectoral | 4 (3.7) | 2 (2.2) | 0 | |
| Sensing configuration RV, n (%) | 0.539 | |||
| True bipolar | 82 (76.6) | 70 (77.8) | 12 (70.6) | |
| Integrated bipolar | 25 (23.4) | 20 (22.2) | 5 (29.4) | |
| ICD system, n (%) | 0.083 | |||
| Single-chamber ICD | 36 (33.6) | 34 (37.8) | 2 (11.8) | |
| Dual-chamber ICD | 23 (21.5) | 19 (21.1) | 4 (23.5) | |
| CRT-D | 48 (44.9) | 37 (41.1) | 11 (64.7) | |
| Device manufacturer, n (%) | 0.012 | |||
| Medtronic | 27 (25.2) | 27 (30) | 0 (0) | |
| Biotronik | 34 (31.8) | 29 (32.2) | 5 (29.4) | |
| Boston Scientific | 25 (23.4) | 19 (21.1) | 6 (35.3) | |
| Abbott | 21 (19.6) | 15 (16.7) | 6 (35.3) | |
| . | All patients (N = 107) . | Patients without EMI (n = 90) . | Patients with EMI (n = 17) . | P-value . |
|---|---|---|---|---|
| Patient characteristics | ||||
| Gender, n (%) | 0.231 | |||
| Male | 93 (86.9) | 80 (88.9) | 13 (76.5) | |
| Female | 14 (13.1) | 10 (11.1) | 4 (23.5) | |
| Age (years) | 73.5 (64.6–78.3) | 73.1 (64.5–78.2) | 76.8 (69.5–79.2) | 0.257 |
| BMI (kg/m²) | 27.1 (24.8–30.9) | 27.1 (24.8–30) | 27.5 (25.1–30.5) | 0.997 |
| Cardiomyopathy, n (%) | 0.529 | |||
| Ischaemic | 55 (51.4) | 48 (53.3) | 7 (41.2) | |
| Dilated | 30 (28.0) | 24 (26.7) | 6 (35.3) | |
| Inflammatory | 7 (6.5) | 6 (6.7) | 1 (5.9) | |
| Hypertrophic | 5 (4.7) | 5 (5.6) | 0 (0) | |
| Other | 10 (9.4) | 7 (7.8) | 3 (17.7) | |
| ICD indication, n (%) | 0.773 | |||
| Primary prevention | 75 (70.1) | 64 (71.1) | 11 (64.7) | |
| Secondary prevention | 32 (29.9) | 26 (28.9) | 6 (35.3) | |
| Heart rhythm, n (%) | 0.129 | |||
| Sinus rhythm | 87 (81.3) | 76 (84.4) | 11 (64.7) | |
| Atrial fibrillation | 14 (13.1) | 10 (11.1) | 4 (23.5) | |
| Third-degree AV block | 6 (5.6) | 4 (4.4) | 2 (11.8) | |
| Device characteristics | ||||
| Device location, n (%) | 0.118 | |||
| Left pectoral | 103 (96.3) | 88 (97.8) | 15 (88.2) | |
| Right pectoral | 4 (3.7) | 2 (2.2) | 0 | |
| Sensing configuration RV, n (%) | 0.539 | |||
| True bipolar | 82 (76.6) | 70 (77.8) | 12 (70.6) | |
| Integrated bipolar | 25 (23.4) | 20 (22.2) | 5 (29.4) | |
| ICD system, n (%) | 0.083 | |||
| Single-chamber ICD | 36 (33.6) | 34 (37.8) | 2 (11.8) | |
| Dual-chamber ICD | 23 (21.5) | 19 (21.1) | 4 (23.5) | |
| CRT-D | 48 (44.9) | 37 (41.1) | 11 (64.7) | |
| Device manufacturer, n (%) | 0.012 | |||
| Medtronic | 27 (25.2) | 27 (30) | 0 (0) | |
| Biotronik | 34 (31.8) | 29 (32.2) | 5 (29.4) | |
| Boston Scientific | 25 (23.4) | 19 (21.1) | 6 (35.3) | |
| Abbott | 21 (19.6) | 15 (16.7) | 6 (35.3) | |
Quantitative variables are shown as median (IQR).
AV, atrioventricular; BMI, body mass index; CRT-D, cardiac resynchronization therapy with defibrillator; EMI, electromagnetic interference; ICD, implantable cardioverter-defibrillator; RV, right ventricle.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
